Product
Fexinidazole
2 clinical trials
5 indications
Indication
Hepatic Function AbnormalIndication
TrypanosomiasisIndication
AfricanIndication
African TrypanosomiasisIndication
Trypanosomiasis; GambianClinical trial
A Multicentric, Open-label, Non-randomized, Pharmacokinetic and Tolerability Study of Fexinidazole Given as an Oral Single 1200 mg Dose in Participants With Mild and Moderate Hepatic Impairment, and in Matched Participants With Normal Hepatic FunctionStatus: Completed, Estimated PCD: 2023-05-03
Clinical trial
An Open-label Study Assessing Effectiveness, Safety and Compliance With Fexinidazole in Patients With Human African Trypanosomiasis Due to T.b. Gambiense at Any StageStatus: Completed, Estimated PCD: 2021-02-01